Related Experiment Video
Updated: Jul 13, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans
Giovanna Simonetti1, Claudio Passariello, Dante Rotili
1Department of Public Health Sciences, University of Rome La Sapienza, Rome Italy.
Abstract:
Candida albicans is able to establish mucosal and invasive diseases by means of different virulence factors that are frequently regulated by epigenetic mechanisms, including the acetylation-deacetylation of histones and of other regulatory proteins. The focus of our work was on understanding the possible effects of several histone deacetylase inhibitors (HDACi) on the expression of phenotypes that are associated with virulence and pathogenicity in C. albicans, such as adhesion to epithelial cells and the yeast to hypha transition. Some of the HDACi used for experiments caused a 90% reduction in the adherence of C. albicans to human cultured pneumocytes and significantly inhibited serum-induced germination. Inhibition of germination was correlated with a significant reduction in transcription of EFG1. Inhibition appeared less evident when an HDA1-deficient strain was tested. These results suggest that selective and specific HDACi could prove to be a valid approach for selected at-risk patients in the combined treatment of infections caused by C. albicans.
Insights
Histone deacetylase inhibitors (HDACi) significantly reduced Candida albicans virulence factors like cell adhesion and hypha formation. This suggests HDACi could be a valuable addition to antifungal treatments for C. albicans infections.
Area of Science:
- Microbiology
- Epigenetics
- Molecular Biology
Background:
- Candida albicans utilizes virulence factors regulated by epigenetic mechanisms, such as histone acetylation/deacetylation.
- Understanding these epigenetic controls is crucial for developing novel therapeutic strategies against C. albicans infections.
Purpose of the Study:
- To investigate the impact of various histone deacetylase inhibitors (HDACi) on C. albicans virulence phenotypes.
- To assess the effects of HDACi on fungal adhesion and the yeast-to-hypha transition.
Main Methods:
- Treatment of C. albicans with selected HDAC inhibitors.
- Assay of fungal adherence to human pneumocytes.
- Measurement of serum-induced yeast germination.
- Quantitative analysis of EFG1 gene transcription.
- Testing of an HDA1-deficient C. albicans strain.
Main Results:
- Certain HDAC inhibitors reduced C. albicans adherence to human pneumocytes by up to 90%.
- HDAC inhibitors significantly inhibited serum-induced germination, correlating with reduced EFG1 transcription.
- Inhibition of germination was less pronounced in an HDA1-deficient strain.
Conclusions:
- Specific HDAC inhibitors demonstrate potential in reducing C. albicans virulence.
- HDAC inhibitors may offer a viable therapeutic approach for managing C. albicans infections, particularly in combination therapies for at-risk patients.
Related Concept Videos
Candidiasis
Antifungal Agents
Antiviral Nucleoside Inhibitors
Fungal Phylum Microsporidia
Inhibitors of Viral Protein Synthesis
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...

